77 related articles for article (PubMed ID: 18096499)
1. Emetine and the alternative splicing of Bcl-X: where to next?
Shultz JC; Chalfant CE
Chem Biol; 2007 Dec; 14(12):1313-4. PubMed ID: 18096499
[TBL] [Abstract][Full Text] [Related]
2. Emetine regulates the alternative splicing of Bcl-x through a protein phosphatase 1-dependent mechanism.
Boon-Unge K; Yu Q; Zou T; Zhou A; Govitrapong P; Zhou J
Chem Biol; 2007 Dec; 14(12):1386-92. PubMed ID: 18096507
[TBL] [Abstract][Full Text] [Related]
3. Protein phosphatase 1 activation and alternative splicing of Bcl-X and Mcl-1 by EGCG + ibuprofen.
Kim MH
J Cell Biochem; 2008 Jul; 104(4):1491-9. PubMed ID: 18348186
[TBL] [Abstract][Full Text] [Related]
4. A cross-talk between RNA splicing and signaling pathway alters Fas gene expression at post-transcriptional level: alternative splicing of Fas mRNA in the leukemic U937 cells.
Aratake K; Kamachi M; Iwanaga N; Kawasaki E; Izumi Y; Ida H; Tanaka F; Tamai M; Arima K; Nakamura H; Origuchi T; Kawakami A; Eguchi K
J Lab Clin Med; 2005 Sep; 146(3):184-91. PubMed ID: 16131458
[TBL] [Abstract][Full Text] [Related]
5. Homoharringtonine regulates the alternative splicing of Bcl-x and caspase 9 through a protein phosphatase 1-dependent mechanism.
Sun Q; Li S; Li J; Fu Q; Wang Z; Li B; Liu SS; Su Z; Song J; Lu D
BMC Complement Altern Med; 2018 May; 18(1):164. PubMed ID: 29788973
[TBL] [Abstract][Full Text] [Related]
6. The expression of Bcl-XL, Bcl-XS and p27Kip1 in topotecan-induced apoptosis in hepatoblastoma HepG2 cell line.
Zhang J; Cheng C; He CL; Zhou YJ; Cao Y
Cancer Invest; 2008 Jun; 26(5):456-63. PubMed ID: 18568767
[TBL] [Abstract][Full Text] [Related]
7. Regulation of alternative splicing of Bcl-x by IL-6, GM-CSF and TPA.
Li CY; Chu JY; Yu JK; Huang XQ; Liu XJ; Shi L; Che YC; Xie JY
Cell Res; 2004 Dec; 14(6):473-9. PubMed ID: 15625014
[TBL] [Abstract][Full Text] [Related]
8. [Regulation of pre-mRNA alternative spicing in U251 cells by TPA].
Li CY; Chu JY; Liu XJ; Yu JK; Huang XQ; ShiI L; Zhu YZ; Na JB; Xie JY
Yi Chuan Xue Bao; 2004 Oct; 31(10):1037-44. PubMed ID: 15552036
[TBL] [Abstract][Full Text] [Related]
9. Dietary isothiocyanate mediated apoptosis of human cancer cells is associated with Bcl-xL phosphorylation.
Basu A; Haldar S
Int J Oncol; 2008 Oct; 33(4):657-63. PubMed ID: 18813778
[TBL] [Abstract][Full Text] [Related]
10. Splice variants in apoptotic pathway.
Miura K; Fujibuchi W; Unno M
Exp Oncol; 2012 Oct; 34(3):212-7. PubMed ID: 23070006
[TBL] [Abstract][Full Text] [Related]
11. Regulation of alternative splicing of Bcl-x by BC200 contributes to breast cancer pathogenesis.
Singh R; Gupta SC; Peng WX; Zhou N; Pochampally R; Atfi A; Watabe K; Lu Z; Mo YY
Cell Death Dis; 2016 Jun; 7(6):e2262. PubMed ID: 27277684
[TBL] [Abstract][Full Text] [Related]
12. A novel histone deacetylase inhibitor, CG0006, induces cell death through both extrinsic and intrinsic apoptotic pathways.
Hwang JJ; Kim YS; Kim MJ; Jang S; Lee JH; Choi J; Ro S; Hyun YL; Lee JS; Kim CS
Anticancer Drugs; 2009 Oct; 20(9):815-21. PubMed ID: 19644355
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B
Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538
[TBL] [Abstract][Full Text] [Related]
14. Involvement of Fractin in TGF-beta-induced apoptosis in oligodendroglial progenitor cells.
Schulz R; Vogel T; Mashima T; Tsuruo T; Krieglstein K
Glia; 2009 Nov; 57(15):1619-29. PubMed ID: 19330858
[TBL] [Abstract][Full Text] [Related]
15. Cellular signals modulate alternative splicing.
Tarn WY
J Biomed Sci; 2007 Jul; 14(4):517-22. PubMed ID: 17385059
[TBL] [Abstract][Full Text] [Related]
16. The role of KLF6 and its splice variants in cancer therapy.
DiFeo A; Martignetti JA; Narla G
Drug Resist Updat; 2009; 12(1-2):1-7. PubMed ID: 19097929
[TBL] [Abstract][Full Text] [Related]
17. Anticancer drugs affect the alternative splicing of Bcl-x and other human apoptotic genes.
Shkreta L; Froehlich U; Paquet ER; Toutant J; Elela SA; Chabot B
Mol Cancer Ther; 2008 Jun; 7(6):1398-409. PubMed ID: 18566212
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous treatment with camptothecin and valproic acid suppresses induction of Bcl-X(L) and promotes apoptosis of MCF-7 breast cancer cells.
Arakawa Y; Saito S; Yamada H; Aiba K
Apoptosis; 2009 Sep; 14(9):1076-85. PubMed ID: 19641995
[TBL] [Abstract][Full Text] [Related]
19. BCL-XL regulates TNF-alpha-mediated cell death independently of NF-kappaB, FLIP and IAPs.
Gozzelino R; Sole C; Llecha N; Segura MF; Moubarak RS; Iglesias-Guimarais V; Perez-Garcia MJ; Reix S; Zhang J; Badiola N; Sanchis D; Rodriguez-Alvarez J; Trullas R; Yuste VJ; Comella JX
Cell Res; 2008 Oct; 18(10):1020-36. PubMed ID: 18591962
[TBL] [Abstract][Full Text] [Related]
20. SBDS-deficient cells undergo accelerated apoptosis through the Fas-pathway.
Rujkijyanont P; Watanabe K; Ambekar C; Wang H; Schimmer A; Beyene J; Dror Y
Haematologica; 2008 Mar; 93(3):363-71. PubMed ID: 18268284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
